NCT03541278 Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique Status UNKNOWN Phase NA
NCT03541161 Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients Status COMPLETED Phase N/A
NCT03540251 Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women Status UNKNOWN Phase NA
NCT03538483 Erector Spinae Plane Block Versus Serratus Plane Block for Breast Surgery Status COMPLETED Phase NA
NCT03536897 IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry Status RECRUITING Phase N/A
NCT03535961 Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03535012 Sensory Recovery of Reconstructed Breast With Breast Reconstructive Options Status UNKNOWN Phase N/A
NCT03530722 Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies Status COMPLETED Phase N/A
NCT03529383 Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer Status COMPLETED Phase NA
NCT03529110 DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03523585 DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] Status COMPLETED Phase PHASE3
NCT03523572 Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer Status COMPLETED Phase PHASE1
NCT03520218 Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities Status COMPLETED Phase NA
NCT03519438 Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis Status COMPLETED Phase N/A
NCT03518957 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers Status RECRUITING Phase PHASE3
NCT03518606 Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1/PHASE2